ATHENS, Greece, Nov. 15, 2019 /PRNewswire/ -- A second baby has
been born via the medical method of Maternal Spindle Transfer, in
the context of clinical research being carried out by the
scientific team of the 'Institute of Life' and 'Embryotools' in
Greece. In the framework of this
clinical research, the Maternal Spindle Transfer is being
investigated as a means to treat infertility problems deriving from
cytoplasmic dysfunction of the oocytes and prevention of serious
inherited mitochondrial diseases' transmission.
The infant was born at 07:00 am on
November 11th, 2019, to a
Greek mother with a long history of 10 IVF failures. Both the
mother and the infant are in very good health.
The attending obstetrician – surgeon – gynaecologist, Dr.
Ioannis P. Vasilopoulos, made
the following statement: "I am very happy that today the second
baby was brought into the world via the maternal spindle transfer
method in the context of the clinical research being carried out by
the scientific team of the Institute of Life and Embryotools. A
Greek woman with a long history of failed IVF attempts was able to
become a mother with her own genetic material!"
The scientific collaborator of Institute of Life and Co-Founder
of Embryotools, Dr.
Nuno Costa-Borges,
highlighted that: "The scientific team continues its clinical
research at the Institute of Life - IASO laboratory, which we
believe will be completed soon".
You may recall that the birth of the first baby via the maternal
spindle transfer method, in the context of the specific clinical
research, was carried out in Greece, by the scientific team of the
Institute of Life and Embryotools, in early April 2019. The infant is now seven months old
and in excellent health.
About the Maternal Spindle Transfer Method
The Maternal Spindle Transfer method involves mitochondrial
replacement in human oocytes, fully preserving the genetic material
of the woman who wants to reproduce. In this way, in the context of
the clinical research being carried out by the Institute of Life
and Embryotools, the scientific team is researching the potential
to overcome the problems of women with fertility issues and
multiple IVF failures caused by cytoplasmic dysfunctions of their
oocytes, and the implementation of the method for the prevention of
the transmission of serious mitochondrial diseases.
Important Note:
Births of children via the Maternal Spindle Transfer method are
carried out in the context of an ongoing research protocol
concerning clinical research leading to pregnancy and conducted in
accordance with the terms and conditions of Law 3305/2005. Based on
current scientific data, the Maternal Spindle Transfer method is
not an established infertility treatment, nor a recognized method
of medically assisted reproduction.
For more information: https://www.iolife.eu/
Logo -
https://mma.prnewswire.com/media/1030045/Institute_of_Life_Logo.jpg